SPARC Antikörper
Kurzübersicht für SPARC Antikörper (ABIN1450173)
Target
Alle SPARC Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Recognizes Human and Bovine bone Osteonectin, Human platelet Osteonectin. SPARC produced by various cells grown in culture. Cross reacts with Rat Osteonectin.Aff. Const.:5 x 10e-9 M
-
Aufreinigung
- Ammonium Sulfate Precipitation, Ion Exchange Chromatography and Gel Filtration.
-
Immunogen
- Crude bone extract containing native Osteonectin.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 10.8 mg/mL (OD280 nm, E1% = 14)
-
Buffer
- 50 % Glycerol/H2O (vol/vol), None
-
Konservierungsmittel
- Without preservative
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C/-80 °C
-
Informationen zur Lagerung
- Store lyophilized (preferably in a desiccator) at -20 °C and in aliquots at -80 °C. Reconstituted antibody can be stored at 4 °C for a limited period of time, it does not show decline in activity after two weeks at 4 °C.
-
-
- SPARC (Secreted Protein, Acidic, Cysteine-Rich (Osteonectin) (SPARC))
-
Andere Bezeichnung
- SPARC / Osteonectin
-
Hintergrund
- SPARC (secreted protein acidic and rich in cysteine)/Osteonectin is a matricellular glycoprotein that modulates cellular interactions with the ECM and is expressed in tissues undergoing remodeling. It functions as a de-adhesive protein, as a modulator of growth factor activity, and as a cell-cycle inhibitor. It induces changes in endothelial cell shape via F-actin, coincident with the appearance of intercellular gaps, that provide a paracellular pathway for extravasation of macromolecules. Tumor growth is enhanced in mice lacking SPARC due to changes in the ECM that create a more permissive environment for tumor progression.Synonyms: BM-40, Basement-membrane protein 40, ON, Secreted protein acidic and rich in cysteine
-
Gen-ID
- 6678
-
NCBI Accession
- NP_003109
-
UniProt
- P09486
-
Pathways
- Autophagie
Target
-